Additionally, we provide a number of early prognostic markers for the onset of severe COVID-19, such as CD14+/CD16+ monocytes ratio, CD4+/CD8+T cell ratio, GZMK+/GZMB+ T cell ratio, etc., although these parameters require further validation in the larger cohorts. This evidence concerns the gene FCGR3A and COVID-19.